an RDP Pharma Company
Innovation & Vision
RDP Pharma AG is a privately held biotech and seed investor based in Romanshorn, Switzerland, that was founded by an international group of industry veterans with decades of experience. Our core team has a highly successful, proven track record of bringing new medications to the market, particularly in the field of oncology.
At RDP Pharma, we identify and acquire new therapeutic modalities to create breakthrough medicines poised to be game-changing life sciences technologies that are at an innovation inflection point.
When technology is about to move from ‘great science’ to ‘great impact’ for patients and healthcare systems. We aim to rapidly develop these technologies (targeted protein degradation, new chemical entities) through deep expertise to key value inflection points (IND ready, clinical trial ready) where the value to a patient population is demonstrated.
Dedication - Expertise - Passion.
Our experienced and dedicated leadership team
Chief Executive Officer
Chief Scientific Officer
Dr. Christian Kühne
Chief Technology Officer
Dr. Michael Ahrweiler
Chief Operating Officer
Dr. Luis Bettinelli
Chief Medical Officer
Priv.-Doz. Dr. med. Dr. rer. nat. Udo Kiessling
Drug Development, Drug Safety, Regulatory Affairs and QA
Dr. Wolfgang Meyer